Consonance Capital Management LP Mersana Therapeutics, Inc. Transaction History

Consonance Capital Management LP

  • $7.28 Million
  • Q3 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021
SELL
$15.31 - $26.52 $21.5 Million - $37.2 Million
-1,401,703 Closed
0 $0
Q4 2020

Feb 16, 2021
SELL
$16.84 - $27.59 $34.8 Million - $57 Million
-2,066,468 Reduced 59.58%
1,401,703 $37.3 Million
Q3 2020

Nov 16, 2020
SELL
$16.2 - $25.7 $39.3 Million - $62.4 Million
-2,428,155 Reduced 41.18%
3,468,171 $64.6 Million
Q2 2020

Aug 14, 2020
BUY
$5.24 - $23.4 $30.9 Million - $138 Million
5,896,326 New
5,896,326 $138 Million

Others Institutions Holding MRSN

# of Institutions
121
Shares Held
116M
Call Options Held
233K
Put Options Held
457K
View Full List

About Mersana Therapeutics, Inc.

MRSN Quotes by TradingView
  • Ticker MRSN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,169,296
  • Market Cap $149M
  • Description
  • Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...
More about MRSN
Track This Portfolio

Track Consonance Capital Management LP Portfolio

Follow Consonance Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Consonance Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Consonance Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email